AC Immune (ACIU) May Find a Bottom Soon, Heres Why You Should Buy the Stock Now
AC Immune (ACIU) appears to have found support after losing some value lately, as indicated by the formation of a…
2,282€
-4,12%
Echtzeit-Aktienkurs AC Immune SA
Bid:
Ask:
Nachrichten zur AC Immune SA Aktie
AC Immune Aktie +15%: "Great News" bei Eli Lilly-Deal - Tau lebt!
Bad Marienberg (www.aktiencheck.de) - AC Immune-Aktie +15,19%: Tau-Deal mit Eli Lilly entfacht Biotech-Rally ????Kursexplosion und Momentum: Anleger springen aufDie AC…
AC Immune stock surges on amended Lilly collaboration deal
AC Immune stock surges on amended Lilly collaboration deal…
AC Immune (ACIU) Upgraded to Buy: Heres Why
AC Immune (ACIU) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine
First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune’s ACI-19626 in Precision Medicine…
AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
AC Immune (ACIU) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
ACIU Stock Crashes 18.3% in a Month: Buy, Sell or Hold?
AC Immunes shares decline 18.3% in a month. While the companys pipeline progress is encouraging, we advise investors to remain…
AC Immune (NASDAQ:ACIU) investors are sitting on a loss of 52% if they invested five years ago
Statistically speaking, long term investing is a profitable endeavour. But unfortunately, some companies simply dont...…
AC Immune (ACIU) Upgraded to Strong Buy: Heres What You Should Know
AC Immune (ACIU) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings…
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions…
AC Immune: Takeda Partnership Brings Funds To Drive Pipeline Forward
…
The Zacks Analyst Blog Highlights Biogen, Eli Lillys, Prothena and AC Immune (Revised)
Biogen, Eli Lillys, Prothena and AC Immune are included in this Analyst Blog.…
AC Immune: Aktie meldet sich an der Börse mit sattem Kursplus zurück - Aktienanalyse
Kulmbach (www.aktiencheck.de) - AC Immune-Aktienanalyse von "Der Aktionär":
Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie…
AC Immune: Hopp-Beteiligung explodiert nach Alzheimer-Deal
Mit einem satten Kursplus von gut 50 Prozent meldet sich der Biotech-Small-Cap AC Immune zum Beginn der neue Handelswoche an…
AC Immune: Hopp-Beteiligung explodiert nach Alzheimer-Deal
Mit einem satten Kursplus von gut 50 Prozent meldet sich der Biotech-Small-Cap AC Immune zum Beginn der neue Handelswoche an…
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease…
AC Immune verringert Verlust - wichtige Daten in der zweiten Jahreshälfte 2024
Das Schweizer Biotech-Unternehmen AC Immune hat Zahlen für das Jahr 2023 vorgelegt. Mit einem Cash-Bestand von 103 Millionen Schweizer Franken…